Nasal eosinophilia and serum soluble intercellular adhesion molecule 1 in patients with allergic rhinitis treated with montelukast alone or in combination with desloratadine or levocetirizine

American Journal of Rhinology and Allergy

Volumn 27, Issue 2, 2013, Pages

  Ciebiada, Maciej ^a   Barylski, Marcin ^a   Ciebiada, Malgorzata Gorska ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

DESLORATADINE; INTERCELLULAR ADHESION MOLECULE 1; LEVOCETIRIZINE; MONTELUKAST; PLACEBO;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EOSINOPHILIA; EVENING DOSAGE; FEMALE; HUMAN; HUMAN CELL; LUNG FUNCTION TEST; MALE; MONOTHERAPY; MORNING DOSAGE; NEUTROPHILIA; PERIPHERAL CIRCULATION; PRICK TEST; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION;

ACETATES; ADULT; ANIMALS; CETIRIZINE; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; EOSINOPHILIA; FEMALE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LEUKOTRIENE ANTAGONISTS; LORATADINE; MALE; NOSE; PROSPECTIVE STUDIES; PYROGLYPHIDAE; QUINOLINES; RHINITIS, ALLERGIC, PERENNIAL;

EID: 84876025520     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2013.27.3881     Document Type: Article

References (40)

1. Cotran RS, and Mayadas-Norton T. Endothelial adhesion molecules in health and disease. Pathol Biol 46:164-170, 1998.
2. Tsakadze NL, Zhao Z, and D'Souza SE. Interactions of intercellular adhesion molecule-1 with fibrinogen. Trends Cardiovasc Med 12: 101-108, 2002.
3. Gearing AJ, and Newman W. Circulating adhesion molecules in disease. Immunol Today 14:506-512, 1993.
4. Rieckmann P, Michel U, Albrecht M, et al. Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells. J Neuroimmunol 60:9-15, 1995.
5. Rothlein R, Mainolfi EA, Czajkowski M, and Marlin SD. A form of circulating ICAM-1 in human serum. J Immunol 147:3788-3793, 1991.
6. Seth R, Raymond FD, and Makgoba MW. Circulating ICAM-1 isoforms: Diagnostic prospects for inflammatory and immune disorder. Lancet 1:83-84, 1991.
7. van de Stolpe A, and van der Saag PT. Intercellular adhesion molecule-1. J Mol Med 74:13-33, 1996.
8. Ohashi Y, Nakai Y, and Tanaka A. Soluble intercellular adhesion molecule-1 level in sera is elevated in perennial allergic rhinitis. Laryngoscope 107:932-935, 1997.
9. Pitsch T, and Rogala B. Steżenie czasteczki sICAM1 w surowicy chorych z alergia atopowa. Alergia Astma Immunologia 8:39-44, 2003.
10. Peric Popadic A, Bogic M, Jovicic Z, et al. The influence of atopy on sICAm-1 serum levels in patients with allergic rhinitis and bronchial asthma. Med Biochem 23:355-359, 2004.
11. Stelmach I, Jerzynska J, and Kuna P. A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein (ECP), soluble interleukin 2 receptor (sIL-2R), IL-4, and soluble intercellular adhesion molecule 1 (sICAM-1) in children with asthma. J Allergy Clin Immunol 109:257-263, 2002.
12. Kramer MF, Ostertag P, Pfrogner E, and Rasp G. Nasal interleukin-5, immunoglobulin E, eosinophilic cationic protein, and soluble intercellular adhesion molecule-1 in chronic sinusitis, allergic rhinitis, and nasal polyposis. Laryngoscope 110:1056-1062, 2000.
13. Pelikan Z. Delayed asthmatic response: A new phenotype of bronchial response to allergen challenge and soluble adhesion molecules in the serum. Ann Allergy Asthma Immunol 106:119-130, 2011.
14. Mullol J, de Borja Callejas F, Marti'nez-Anto'n MA, et al. Mometasone and desloratadine additive effect on eosinophil survival and cytokine secretion from epithelial cells. Respir Res 27:12-23, 2011.
15. Caproni M, Volpi W, Giomi B, et al. Cellular adhesion molecules in chronic urticaria: Modulation of serum levels occurs during levocetirizine treatment. Br J Dermatol 155:1270-1274, 2006.
16. Fasce L, Ciprandi G, Pronzato C, et al. Cetirizine reduces ICAM-I on epithelial cells during nasal minimal persistent inflammation in asymptomatic children with mite-Allergic asthma. Int Arch Allergy Immunol 109:272-276, 1996.
17. Park CS, Cho JH, Kang JM, et al. Levocetirizine has anti-inflammatory effects against Toll-like receptor (TLR)3 through the inhibition of Toll-IL-1 receptor (TIR)-domain-containing adapter inducing IFNbeta (TRIF) and receptor-interacting protein (RIP). Auris Nasus Larynx 38:474-479, 2011. (Epub Feb 16, 2011.
18. Ciebiada M, Gorska-Ciebiada M, Barylski M, et al. Use of montelukast alone or in combination with desloratadine or levocetirizine in patients with persistent allergic rhinitis. Am J Rhinol Allergy 25:e1-e6, 2011.
19. Schaper C, Gustavus B, Koch B, et al. Effects of fexofenadine on inflammatory mediators in nasal lavage fluid in intermittent allergic rhinitis. J Investig Allergol Clin Immunol 19:459-464, 2009.
20. Ciebiada M, Go'rska-Ciebiada M, DuBuske LM, and Go'rski P. Montelukast with desloratadine or levocetirizine for the treatment of persistent allergic rhinitis. Ann Allergy Asthma Immunol 97:664-671, 2006.
21. Ciebiada M, Ciebiada MG, Kmiecik T, et al. Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine. J Investig Allergol Clin Immunol 18:343-349, 2008.
22. Kosik-Bogacka DI, Kalisinska E, Henszel L, and Kuzna-Grygiel W. Seasonal dynamics of house dust mites in dust samples collected from sleeping places in north-western Poland. Zoonoses Public Health 59:8-15, 2012.
23. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 63(Suppl 86):8-160, 2008.
24. Cockroft DW, Killian DN, Mellon JJ, and Hargreave FE. Bronchial reactivity to inhaled histamine: A method and clinical survey. Clin Allergy 7:235-243, 1977.
25. Meltzer EO, Malmstrom K, Lu S, et al. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trial. J Allergy Clin Immunol 105:917-922, 2000.
26. Kurowski M, Kuna P, and Go'rski P. Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: Influence on clinical symptoms and nasal allergic inflammation. Allergy 59:280-288, 2004.
27. Yamamoto H, Yamada T, Sakashita M, et al. Efficacy of prophylactic treatment with montelukast and montelukast plus add-on loratadine for seasonal allergic rhinitis. Allergy Asthma Proc 33:e17-e22, 2012.
28. Lagos JA, and Marshall GD. Montelukast in the management of allergic rhinitis Ther Clin Risk Manag 3:327-332, 2007.
29. Sardana N, Santos C, Lehman E, and Craig T. A comparison of intranasal corticosteroid, leukotriene receptor antagonist, and topical antihistamine in reducing symptoms of perennial allergic rhinitis as assessed through the Rhinitis Severity Score. Allergy Asthma Proc 31:5-9, 2010.
30. Leonardi A, DeFranchis G, De Paoli M, et al. Histamine-induced cytokine production and ICAM-1 expression in human conjunctival fibroblasts. Curr Eye Res 25:189-196, 2002.
31. Profita M, Sala A, Bonanno A, et al. Cysteinyl leukotriene-1 receptor activation in a human bronchial epithelial cell line leads to signal transducer and activator of transcription 1-mediated eosinophil adhesion. J Pharmacol Exp Ther 325:1024-1030, 2008.
32. Kushiya M, Saito K, Kikuchi I, et al. Differential effects of salbutamol and montelukast on eosinophil adhesion and superoxide anion generation. Int Arch Allergy Immunol 140:17-22, 2006.
33. Yang CM, Luo SF, Hsieh HL, et al. Interleukin-1beta induces ICAM-1 expression enhancing leukocyte adhesion in human rheumatoid arthritis synovial fibroblasts: Involvement of ERK, JNK, AP-1, and NF-kappaB. J Cell Physiol 224:516-526, 2010.
34. Li H, and Nord EP. IL-8 amplifies CD40/CD154-mediated ICAM-1 production via the CXCR-1 receptor and p38-MAPK pathway in human renal proximal tubule cells. Am J Physiol Renal Physiol 296:438-445, 2009.
35. Ciebiada M, Gorska-Ciebiada M, and Gorski P. sICAM-1 and TNF-in asthma and rhinitis: Relationship with the presence of atopy. J Asthma 48:660-666, 2011.
36. Andersson K, Shebani EB, Makeeva N, et al. Corticosteroids and montelukast: Effects on airway epithelial and human umbilical vein endothelial cells. Lung 188:209-216, 2010.
37. Ciebiada M, Gorska-Ciebiada M, and Gorski P. Fexofenadine with either montelukast or a low-dose inhaled corticosteroid (fluticasone) in the treatment of patients with persistent allergic rhinitis and newly diagnosed asthma. Arch Med Sci 5:564-569, 2009.
38. Jang YJ, Wang JH, Kim JS, et al. Levocetirizine inhibits rhinovirusinduced ICAM-1 and cytokine expression and viral replication in airway epithelial cells. Antiviral Res 81:226-233, 2009.
39. Papi A, Papadopoulos NG, Stanciu LA, et al. Effect of desloratadine and loratadine on rhinovirus-induced intercellular adhesion molecule 1 upregulation and promoter activation in respiratory epithelial cells. J Allergy Clin Immunol 108:221-228, 2001.
40. Meliton AY, Munoz NM, and Leff AR. Blockade of avidity and focal clustering of beta 2-integrin by cysteinyl leukotriene antagonism attenuates eosinophil adhesion. J Allergy Clin Immunol 120:1316-1323, 2007.